Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1514

1.

Replication competence of virions induced from CD4+ lymphocytes latently infected with HIV.

Richman DD, Huang K, Lada SM, Sun X, Jain S, Massanella M, Menke B.

Retrovirology. 2019 Feb 15;16(1):4. doi: 10.1186/s12977-019-0466-1.

2.

Host mRNA decay proteins influence HIV-1 replication and viral gene expression in primary monocyte-derived macrophages.

Rao S, Amorim R, Niu M, Breton Y, Tremblay MJ, Mouland AJ.

Retrovirology. 2019 Feb 7;16(1):3. doi: 10.1186/s12977-019-0465-2.

3.

Sequential trafficking of Env and Gag to HIV-1 T cell virological synapses revealed by live imaging.

Wang L, Izadmehr S, Kamau E, Kong XP, Chen BK.

Retrovirology. 2019 Jan 15;16(1):2. doi: 10.1186/s12977-019-0464-3.

4.

Clonal anergy of CD117+chB6+ B cell progenitors induced by avian leukosis virus subgroup J is associated with immunological tolerance.

He S, Zheng G, Zhou D, Li G, Zhu M, Du X, Zhou J, Cheng Z.

Retrovirology. 2019 Jan 3;16(1):1. doi: 10.1186/s12977-018-0463-9.

5.

Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification.

Désiré N, Cerutti L, Le Hingrat Q, Perrier M, Emler S, Calvez V, Descamps D, Marcelin AG, Hué S, Visseaux B.

Retrovirology. 2018 Dec 22;15(1):80. doi: 10.1186/s12977-018-0461-y.

6.

The role of exosomal transport of viral agents in persistent HIV pathogenesis.

Patters BJ, Kumar S.

Retrovirology. 2018 Dec 22;15(1):79. doi: 10.1186/s12977-018-0462-x. Review.

7.

Natural APOBEC3C variants can elicit differential HIV-1 restriction activity.

Anderson BD, Ikeda T, Moghadasi SA, Martin AS, Brown WL, Harris RS.

Retrovirology. 2018 Dec 17;15(1):78. doi: 10.1186/s12977-018-0459-5.

8.

Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir.

Vos AG, Chersich MF, Klipstein-Grobusch K, Zuithoff P, Moorhouse MA, Lalla-Edward ST, Kambugu A, Kumarasamy N, Grobbee DE, Barth RE, Venter WD.

Retrovirology. 2018 Dec 14;15(1):77. doi: 10.1186/s12977-018-0460-z.

9.

Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection.

de Paula HHS, Ferreira ACG, Caetano DG, Delatorre E, Teixeira SLM, Coelho LE, João EG, de Andrade MM, Cardoso SW, Grinsztejn B, Veloso VG, Morgado MG, Guimarães ML, Côrtes FH.

Retrovirology. 2018 Dec 12;15(1):76. doi: 10.1186/s12977-018-0458-6.

10.

MBL2 gene polymorphisms in HHV-8 infection in people living with HIV/AIDS.

de Morais VMS, de Lima ELS, Cahú GGOM, Lopes TRR, Gonçales JP, Muniz MTC, Coêlho MRCD.

Retrovirology. 2018 Nov 27;15(1):75. doi: 10.1186/s12977-018-0456-8.

11.

HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth.

van Schooten J, van Gils MJ.

Retrovirology. 2018 Nov 26;15(1):74. doi: 10.1186/s12977-018-0457-7. Review.

12.

Antibody-mediated prevention and treatment of HIV-1 infection.

Gruell H, Klein F.

Retrovirology. 2018 Nov 16;15(1):73. doi: 10.1186/s12977-018-0455-9. Review.

13.

Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.

Naito T, Yasunaga JI, Mitobe Y, Shirai K, Sejima H, Ushirogawa H, Tanaka Y, Nakamura T, Hanada K, Fujii M, Matsuoka M, Saito M.

Retrovirology. 2018 Nov 6;15(1):72. doi: 10.1186/s12977-018-0454-x.

14.

The role of integration and clonal expansion in HIV infection: live long and prosper.

Anderson EM, Maldarelli F.

Retrovirology. 2018 Oct 23;15(1):71. doi: 10.1186/s12977-018-0448-8. Review.

15.

The expanding array of HIV broadly neutralizing antibodies.

McCoy LE.

Retrovirology. 2018 Oct 16;15(1):70. doi: 10.1186/s12977-018-0453-y. Review.

16.

Host SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophages.

Mahboubi B, Gavegnano C, Kim DH, Schinazi RF, Kim B.

Retrovirology. 2018 Oct 13;15(1):69. doi: 10.1186/s12977-018-0452-z.

17.

Friend retrovirus infection induces the development of memory-like natural killer cells.

Littwitz-Salomon E, Nguyen T, Schimmer S, Dittmer U.

Retrovirology. 2018 Oct 6;15(1):68. doi: 10.1186/s12977-018-0450-1.

18.

RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.

Méndez C, Ledger S, Petoumenos K, Ahlenstiel C, Kelleher AD.

Retrovirology. 2018 Oct 4;15(1):67. doi: 10.1186/s12977-018-0451-0.

19.

Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1.

Lin A, Balazs AB.

Retrovirology. 2018 Oct 1;15(1):66. doi: 10.1186/s12977-018-0449-7. Review.

20.

Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression.

Wang M, Yang W, Chen Y, Wang J, Tan J, Qiao W.

Retrovirology. 2018 Sep 21;15(1):65. doi: 10.1186/s12977-018-0447-9.

Supplemental Content

Loading ...
Support Center